The Republican Unitary Producing Enterprise «Belmedpreparaty»
The Republican Unitary Producing Enterprise «Belmedpreparaty» is the largest pharmaceutical enterprise in the country. Since 1929 it has been producing medicines. Manufactured products belong to more than 20 pharmacological groups. The range of products is more than 350 items.
Today, the Republican Unitary Producing Enterprise «Belmedpreparaty» is the largest pharmaceutical company in the country, which carries out a constant mission – to provide the population of the country with effective, safe and high-quality medicines for prevention and treatment of a wide range of diseases. The significant number of manufactured medicines refers to vital ones.
The main strategy of the company is a dynamic, progressive development, which aimed at:
developing and producing new medicines, both generics and original innovative ones;
providing high-quality manufactured products;
creating new production sites in accordance with the international requirements of GMP (good manufacturing practice);
increasing the competitiveness of products;
introducing progressive energy- and resource-saving technologies for producing substances and finished products;
developing new markets for supplying medicines.
The Republican Unitary Producing Enterprise «Belmedpreparaty» has a number of unique production sites and is the only Belarusian manufacturer of insulin medicines, drugs of endocrine and biotechnological origin, medicines for treating cancer and tuberculosis, narcotic and psychotropic drugs. Almost all types of dosage forms are available: tablets with different coatings and without them, hard and soft gelatin capsules, solutions for injections and infusions in vials and ampoules, lyophilized and sterilely packaged powders for injections and infusions, medicines for eyes (drops), ointments, creams and gels, powders in sachet packages. In general, the company implements a multi-stage producing process based on high technologies, producing more than 350 kinds of medicines.
In partnership with other objects of the market, as well as medical institutions of the Ministry of Health of the Republic of Belarus, the Republican Unitary Producing Enterprise «Belmedpreparaty» aims at ensuring high availability of medicines to improve the quality of patients’ life and their awareness.
Production territory of the enterprise occupies a total area of more than 20 hectares and includes 13 production workshops and 7 additional ones. Geographically, production sites are located in the cities: Minsk (2 sites), Skidel and Lida. Liquid medicines and disinfectants, powders for various purposes, sterically packaged antibiotics are manufactured at the production site in Lida. The production site in Skidel manufactures finished products (in the form of tablets and capsules), as well as biological preparations used in veterinary medicine and agriculture. Each production site has its own engineering infrastructure, which fully meets the needs of existing production sites, as well as has sufficient reserves for further increasing production volumes.
Since the mid-1990s, the company has carried out technical re-equipment of existing production sites, after that effective technologies were introduced to ensure the production of medicines according to the world’s standards; a site producing sterile antibiotics was put into operation, an investment project for producing injection medicines in ampoules and vials was implemented. In 2008, the modernization of tablet and capsule production site was completed. A new workshop complying with the requirements of GMP was commissioned and equipped with modern technologies of leading European manufacturers. In 2013, an investment project was implemented for production of anticancer medicines in the form of lyophilized powders and solutions for injection, for that reason a new building was built. Sites have been created for producing modern effective medicines for complex polychemotherapy for oncological, including onco-hematological, diseases. Unique insulator technologies have been introduced at the production sites. This production site is equipped by leading manufacturers in Italy, the Czech Republic, and Germany.
At the end of 2014, a technological production line of medicines in pre-filled syringes was commissioned, which marked a new stage in the production activities of the Republican Unitary Producing Enterprise «Belmedpreparaty». Medical and healthcare professionals from all over the world recognize and appreciate the benefits of prefilled syringes. In addition, the enterprise is implementing an innovative project for producing transdermal patches. At the end of 2015, a production site for sterile-packaged antibiotics was put into operation. The site includes two isolated areas, is equipped by Italian manufacturers, meets the requirements of GMP.
The Republican Unitary Producing Enterprise «Belmedpreparaty» provides quality at all stages of its activities. At the enterprise the main document of the quality management system is being functioned – the Policy of the top management of the Republican Unitary Producing Enterprise «Belmedpreparaty» in the field of quality, which defines the aims and goals at improving customers’ satisfaction with the products of the Republican Unitary Producing Enterprise «Belmedpreparaty». The company’s management annually assesses the implementation of the Policy and, if necessary, updates it.
In accordance with the approved standards and procedures, input quality control of raw and packaging materials, quality control of non-finished and finished products are being carried out, the stability of medicines is being inspected, samples of substances and finished products are being archived.
The Republican Unitary Producing Enterprise «Belmedpreparaty» carries out measures for monitoring the safety of medicines keeping in touch with regulatory authorities. That reduces the probability of unfavorable effects of the use of medicines. This is due to the identification of risk factors of their development and the working-out on the basis of the obtained data of appropriate recommendations for medical and pharmaceutical personnel, as well as consumers. As a result of efforts for maintaining the quality of products at a high level, the company received Belarusian, Ukrainian and Romanian certificates of GMP standards.
Address: 30 Fabritsyusa Street, Minsk, 220007
Phone: +375 17 228 10 12
Fax: +375 17 216 28 41
Open Joint Stock Company «Borisov Plant of Medical Preparations»
Open Joint Stock Company «Borisov Plant of Medical Preparations» is one of the leading manufacturers and exporters of medicines for wide spectrum of treatment. It is founded in 1965. The constant range of products includes more than 250 names of medicines of 12 pharmacological groups.
The territory area of the plant is over 10 hectares. The number of employees is about 3000 people. The plant produces more than 250 names of medicines – generics – of 12 pharmacological groups. And, regularly, every year at least 10 of the most popular medicines are added to the list of its products. More than 5 billion tablets, 300 million ampoules, 185 million capsules, 50 million vials of antibiotics in the form of sterile powders, 13 million tubes of ointments and gels, 10 million vials of tinctures and alcohol solutions annually produced by the plant, improve people’s health in many countries of the world. For 2018, the volume of industrial products in actual prices is evaluated to 272 million rubles. (eq. – 136 million US dollars).
Medicines manufactured by Open Joint Stock Company «Borisov Plant of Medical Preparations» are supplied regularly not only to the Russian Federation, but also to Azerbaijan, Armenia, Afghanistan, Vietnam, Georgia, Egypt, Iraq, Yemen, Kazakhstan, North Korea, Kyrgyzstan, Latvia, Lebanon, Lithuania, Macedonia, Moldova, Uzbekistan, Ukraine, Somalia, USA, Tajikistan, Turkmenistan, Estonia. In the very near future the plant plans to significantly expand the geography of sales: to enter the markets of South America, Africa, and Asian countries. The active introduction of the GMP quality system at the enterprise contributes to the implementation of these plans.
Traditionally, about half of the production volume manufactured by Open Joint Stock Company «Borisov Plant of Medical Preparations» is exported. The volume of exports in 2018 amounted to 65 million US dollars. Open Joint Stock Company «Borisov Plant of Medical Preparations» focuses attention on constant development and modernization: 300 production technologies are already supplemented with new ones, the equipment is regularly updated, production certification for compliance with GMP standards is carried out consistently. It is worth noting that the priority market for Open Joint Stock Company «Borisov Plant of Medical Preparations» is still BELARUS. Providing the population of the country with high-quality, effective, available medicines is part of the strategy of the plant. Modern equipment, the latest technology, the most accurate methods of product quality control, qualified personnel – all these conditions determine the fact that millions of people in many countries around the world trust the most valuable thing for them – their health.
Address: 64 Chapaeva Street, Borisov, Minsk region, the Republic of Belarus, 222518
Phone: +375 177 73 22 61
Fax: +375 177 73 24 25
Open Joint Stock Company «Nesvizh Plant of Medical Preparations»
Open Joint Stock Company «Nesvizh Plant of Medical Preparations» is the largest manufacturer of infusion medicines in the Republic of Belarus. It is founded in 1960. The assortment of products includes about 70 items.
The status of one of the leading companies in the Belarusian pharmaceutical market obliges to strictly follow international standards and offer consumers effective medicines that passed through multi-level quality control.
The plant’s activities are aimed at recovering, strengthening and keeping sound people’s health. Great experience in the industry, the introduction of innovative technologies have formed a positive image of Open Joint Stock Company «Nesvizh Plant of Medical Preparations».
The set task is high, but only such a level can explain the choice of those who have entrusted the most valuable thing – their health.
Address: 1 Zavodskaya Street, Alba village, Nesvizh district, Minsk region, the Republic of Belarus, 222603
Phone: +375 1770 6 20 01
Fax: +375 1770 6 20 61
Open Joint Stock Company «Ekzon»
Open Joint Stock Company «Ekzon» is a pharmaceutical company that has been manufacturing medicines, biologically active supplements, food products since 1995. The number of medicines produced by the company is more than 70.
Open Joint Stock Company «Ekzon» has been existing in the domestic pharmaceutical market since 1995. The company manufactures products that meet all quality standards. The staff of the enterprise is interested in cooperation with domestic and foreign partners.
The main task is to keep sound health of everybody and improve the quality of life with using natural, effective, high-quality and healthy medicines and biologically active supplements.
The company manufactures products according to European quality, using high quality raw materials. All products manufactured by the company are registered at the Ministry of Health of the Republic of Belarus.
The company has its own quality assurance and quality control service. Highly qualified personnel carries out work on input and intermediate control of raw materials and other ones, as well as during the technical process, control of the quality of finished products, control of storage and sales.
Address: 202 Lenina Street, Droghichin, Brest region, the Republic of Belarus, 225612
Phone: +375 1644 3 07 29
Fax: +375 1644 3 07 29
Open Joint Stock Company «Ferein»
Open Joint Stock Company «Ferein» is a pharmaceutical company that has been manufacturing medicines since 2008. The number of medicines produced by the company is 59.
Open Joint Stock Company «Ferein» is registered in the unified state register of legal entities and individual entrepreneurs in 2008. The owner of the property is the Republic of Belarus – 25%, PJSC “Bryntsalov-A”(Moscow, Russian Federation) – 75%.
The main producing share is made up by injectable medicines produced on a full cycle. Analysis of the dynamics of the development of the Belarusian pharmaceutical market indicates a constant growing need for medicines of Open Joint Stock Company «Ferein». Products of the company are known and in demand.
Сoncentrating on the development and production of modern high-quality medicines with improved characteristics that meet the requirements of effectiveness and safety, expanding the list and forms of products, Open Joint Stock Company «Ferein» aims at achieving the strategic objective of providing consumers with high-quality and safe medicines at available prices.
The implementation of the Quality Policy by the company is achieved with the established and formalized pharmaceutical quality assurance and management system. That system includes operation of all the factors for constant quality assurance and prevention of nonconformities, from input quality control of raw materials to control of releasing and selling finished products, which are primarily carried out by the quality assurance (QA) and quality control (QC) departments, as well as producing and engineering services of the company.
Upholding the policy of making efforts to the implement the Quality Policy, the company makes regular investments in the quality management system, improves technological process.
Achieving a leading position in product quality is a priority strategic task for Open Joint Stock Company «Ferein».
Address: 28-52a Covalevskoy Lane, Minsk, 220014
Phone: +375 17 222 92 18
Fax: +375 17 222 92 18
The Republican Unitary Enterprise «Scientific-Practical Сenter LOTIOS»
The Republican Unitary Enterprise «Scientific-Practical Сenter LOTIOS» is founded in 1997 and works in the field of scientific and practical, instrumental, analytical, methodological support and quality control of products, the safety of their production for humans and the environment.
The Republican Unitary Enterprise «Scientific-Practical Сenter LOTIOS» is a scientific institution.
The Republican Unitary Enterprise «Scientific-Practical Сenter LOTIOS» is registered in the National System of Conformity Attestation of the Republic of Belarus for consulting services to provide companies of the pharmaceutical, veterinary and perfumery and cosmetic industries with methodological assistance in case of developing quality assurance systems in accordance with the principles of GMP and certification.
The analytical laboratory of the Republican Unitary Enterprise «Scientific-Practical Сenter LOTIOS» is accredited for independence and technical competence in accordance with the requirements of ISO/IEC 17025 for testing products and environmental objects (Certificate of Accreditation No. BY/112 02.1.0.0283 from 24.11.1997. It’s valid until February 13, 2020).
The department of experimental medicine and pharmacy of the Republican Unitary Enterprise «Scientific-Practical Сenter LOTIOS» is accredited for compliance with the requirements of ISO/IEC 17025 (Accreditation Certificate No. BY/112 1.1685 of 13.12.2010. It’s valid until December 13,2020).
Environmental services, rendered for inventory of pollution emissions into the atmosphere and drafting of documents for standards of permissible pollution emissions, are certified for compliance with the requirements of ISO 1803 (Certificate No. BY/112 04.19.074.01 of 13.10.2008. It’s valid until October 13, 2019).
Address: 10 Biaduli Street, Minsk, 220034
Phone: +375 17 294 39 54
The Republican Unitary Producing Enterprise «Minskintercaps»
The Republican Unitary Producing Enterprise «Minskintercaps» is the leader of domestic pharmaceutical industry producing medicines in hard and soft gelatin capsules. It is founded in 2001. The range of the company is about 80 items.
The Republican Unitary Producing Enterprise «Minskintercaps» is a pharmaceutical company, which takes a leading position in producing medicines in hard and soft gelatin capsules.
The Republican Unitary Producing Enterprise «Minskintercaps» carries out both a full cycle of production of in-capsule medicines, biologically active supplements and cosmetics, and separate stages of producing (encapsulation, packaging, packaging).
The mission of the enterprise is providing consumers with effective, high-quality, safe medicines.
345 employees work on producing and selling effective and high-quality products.
The enterprise’s product portfolio includes vitamins and vitamin-mineral complexes, medicines for treating cardiovascular diseases, antiviral and anti-cold, nootropic and antiallergic drugs, medicines used in urology and obstetrics and gynecology, neurology, as well as medicines based on medical plant materials.
In 2016, another important stage of development appeared in the enterprise’s history is a new producing complex building which was commissioned and increased a significant production volume.
In 2017 the Republican Unitary Producing Enterprise «Minskintercaps» was awarded the title of «Best Exporter of the Year» in the category «Production of goods intended for treatment and rehabilitation».
The production sites are equipped with modern equipment of the world’s companies: «TECHNOPHAR» (Canada); «GIC» (USA); «IMA» (Italia); «BOSCH» (Germany); «SkySoftgel» (Korea); «Hoonga» (Korea); «Adapta» (Italia) and etc.
Address: 26 Ingenernaya Street, Minsk, the Republic of Belarus, 220075
Phone: +375 17322 28 34
Fax: +375 17322 28 34
The Unitary Producing Enterprise «FreBor»
The Unitary Producing Enterprise «FreBor» is a leading Belarusian manufacturer of safe disposable medical products. It is founded in 1992. The assortment includes about 220 products.
The Unitary Producing Enterprise «FreBor» is a leading Belarusian manufacturer of safe medical products for single usage, the owner of more than a dozen diplomas and prizes for stable product quality. In all aspects of its activity, the goal of all efforts of the enterprise is HEALTH AND QUALITY OF HUMAN LIFE. These words are not only the basis of enterprise’s quality and ecology policy, but also the motto for every employee working at the enterprise.
There are about 220 medical products in the assortment of production. The enterprise is constantly expanding the list of medical products and increasing production volumes. Existing in the market of medical products for more than 25 years, the enterprise has proved itself as a reliable developer and manufacturer of medical products. Many modern management tools and quality improvements have been introduced into manufacturing medical products that meet modern international requirements to ensure the stable development of the enterprise.
For the introduction of highly effective quality management methods and the production of competitive products in 2001, the enterprise was awarded with the Prize of the Government of the Republic of Belarus, which was confirmed in 2004, 2007 and 2012.
A professional approach and a high level of responsibility of employees of the enterprise’s departments contribute to creating medical products that are in demand not only at the territory of the Republic of Belarus but abroad – in Russia, Georgia, Kazakhstan, Azerbaijan, Kyrgyzstan, Uzbekistan.
Address: 5 floor, 64 Chapaeva Street, Borisov, Minsk region, the Republic of Belarus, 222518
Phone: +375 177 73 42 65
Fax: +375 177 73 24 41
According to the Decree of the President of the Republic of Belarus of July 25, 2017 No. 258 «About the holding producing pharmaceutical products» on August 25, 2018,the holding BELPHARMPROM was established.
The managing company of the holding is the Pharmaceutical Holdings Company BELPHARMPROM.
On the date of February 1, 2019, the holding includes 40 entities They are 8 holding’s participants, 32 associated companies, of which: 26 pharmaceutical manufacturers, 5 manufacturers of medical products and 1 manufacturer of veterinary medicines.
Thus, the pharmaceutical enterprises united by the holding BELPHARMPROM produce more than 95% of the volume of domestic medicines.
On the date of January 1, 2019, totally 4,266 medicines were registered in the Republic of Belarus, including 1,674 domestic medicines (95 are original medicines, 1,553 are generic ones) and 23 innovative medicines.